Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Sell

C

Clene Inc. Warrant (CLNNW)

Pharmaceutical Preparations

https://www.clene.com

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements).

6550 SOUTH MILLROCK DRIVE, SUITE G50
SALT LAKE CITY, UT

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/31/2020

Market Cap

31,573,928

Shares Outstanding

128,410,000

Weighted SO

N/A

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

RVPHW --.--%

RVPHW --.--%

ATNFW --.--%

ATNFW --.--%

CLNN --.--%

CLNN --.--%

CLVRW --.--%

CLVRW --.--%

ARTLW --.--%

Beta

0.4590

Last Div

0.0000

Range

0.0499-0.0499

Chg

-0.0001

Avg Vol

N/A

Mkt Cap

31573928

Exch

NASDAQ

Country

US

Phone

801 676 9695

DCF Diff

5.4231

DCF

-0.5431

Div Yield

0.0000

P/S

73.5568

EV Multiple

-1.2946

P/FV

-1280.8131

Div Yield %

0.0000

P/E

-21.1955

PEG

-0.8177

Payout

0.0000

Current Ratio

0.9943

Quick Ratio

0.9930

Cash Ratio

0.7725

DSO

1004.9887

DIO

10.0784

Op Cycle

1015.0670

DPO

290.3657

CCC

724.7014

Gross Margin

-2.0317

Op Margin

-81.6629

Pretax Margin

-68.9050

Net Margin

-68.9050

Eff Tax Rate

-0.3948

ROA

-0.7552

ROE

-3.1597

ROCE

-2.9439

NI/EBT

1.0000

EBT/EBIT

0.8438

EBIT/Rev

-81.6629

Debt Ratio

0.6965

D/E

-55.7321

LT Debt/Cap

1.0774

Total Debt/Cap

1.0183

Int Coverage

-15.3596

CF/Debt

-0.9760

Equity Multi

-80.0198

Rec Turnover

0.3632

Pay Turnover

1.2570

Inv Turnover

36.2162

FA Turnover

0.0358

Asset Turnover

0.0110

OCF/Share

-0.2134

FCF/Share

-0.2142

Cash/Share

0.1688

OCF/Sales

-62.0249

FCF/OCF

1.0038

CF Coverage

-0.9760

ST Coverage

-1.3008

CapEx Coverage

-262.4771

Div&CapEx Cov

-262.4771

P/BV

-1280.8131

P/B

-1280.8131

P/S

73.5568

P/E

-21.1955

P/FCF

-1.1814

P/OCF

-23.5466

P/CF

-23.5466

PEG

-0.8177

P/S

73.5568

EV Multiple

-1.2946

P/FV

-1280.8131

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation